µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
µå·°ÀÎÆ÷¸¦ ½ÃÀÛÆäÀÌÁö·Î   ·Î±×ÀΠȸ¿ø°¡ÀÔ ³»ÄÁÅÙÃ÷ÇÔ contacts
BIT Druginfo
  ½ÅÅëÇÕ°Ë»ö  
¾àǰ°Ë»ö|ÀÓºÎÅõ¿©|ATCºÐ·ùÄÚµå|ÀûÀÀÁõ|ÇѾà(»ý¾à)»çÁø|¾àÈ¿ºÐ·ù
¾àǰ°Ë»ö Á¦Ç°½Äº° »óÈ£ÀÛ¿ë ¼ººÐÁ¤º¸ ȯÀÚº¹¾àÁöµµ ¾àÁ¦ºñ½É»çÁöħ ÇàÀ§°ü·Ã½É»çÁöħ °Ô½ÃÆÇ Ä¿¹Â´ÏƼ
 
 
top
¾ÆÀ̵ðÀúÀå º¸¾ÈÁ¢¼Ó
line
ȸ¿ø°¡ÀÔ ¾ÆÀ̵ðºñ¹Ð¹øÈ£Ã£±â
·Î±ä¹®Á¦
bottom
¾àǰ°Ë»ö
È޹̶óÁÖ40mg
Çٽɿä¾àÁ¤º¸
¿ä¾àÁ¤º¸
»ó¼¼Á¤º¸
´ëü°¡´É/µ¿ÀϼººÐÀǾàǰ
»óÈ£ÀÛ¿ë
°ü·Ã¾àÈ¿ºÐ·ù
°üÀý¿° ¹× ·ù¸¶Æ¼½º Æ÷ÇÔ ±Ù°ñ°Ý°è¾à¹°(Musculoskeletal drugs including arthritis and rheumatic diseases)
°ü·Ã¾à¹°Ã£±â
ȯÀÚº¹¾àÁöµµ
¿ä¾à º¹¾à ¾È³»¹®
»ó¼¼ º¹¾à ¾È³»¹®
Á¦Çüº° º¹¾àÁöµµ
Á¦Ç°º° º¹¾àÁöµµ
Áúȯº° º¹¾àÁöµµ
Á¾ÇÕ º¹¾à ¾È³»¹®
¾àÁ¦ºñ½É»çÁöħ
Adalimumab ÁÖ»çÁ¦(ǰ¸í: È޹̶óÁÖ µî)
·ù¸¶Æ¼½ºÁúȯ¿¡¼­ TNF-¥á inhibitor Á¦Á¦(ǰ¸í: ¿£ºê·¼ÁÖ»ç µî)¸¦ ÈÞ¾à ÈÄ Àç Åõ¿© ½Ã Àû¿ë±âÁØ
»ý¹°ÇÐÀûÁ¦Á¦ ¹× ¼ÒºÐÀÚ¾ïÁ¦Á¦ Åõ¿© Àü Àẹ°áÇÙ°¨¿° Áø´Ü°Ë»ç ½ÃÇà ½Ã±â
½É»ç»ç·Ê
±âŸ °Ë»ö
ATC Äڵ庰
¼ººÐº°
ÀûÀÀÁõº°
º´¿ë±Ý±â ÀǾàǰ
ÀӺαݱâ ÀǾàǰ
ºñ¿ëÈ¿°úÀû ÇÔ·® ÀǾàǰ
ATCÄÚµå °Ë»ö
ÀûÀÀÁõ °Ë»ö
»ý¾à¸í °Ë»ö
Medline °Ë»ö
Adalimumab
My Drug Picture
My Drug List
¿ÀŸ½Å°í
bottom
Á¦Ç°ÄÚµå(KD)
Ç¥ÁØÄÚµå(¹ÙÄÚµå)
ǰ¸ñ±âÁØÄÚµå
bottom

ÇàÀ§Á¤ÀÇ+½É»çÁöħ
ÇàÀ§ Á¤ÀÇ
ÇàÀ§ ½É»çÁöħ
ÇàÀ§Á¤ÀÇ+½É»çÁöħ
ºÎ°¡Á¤º¸°Ë»ö
󹿻ç·Ê
ÀÌ»ó¹ÝÀÀ ¹× ´ëó¹ý
ÀÓ»êºÎ¸¦ À§ÇÑ
¿µ¾ç°ü¸®
ÀǾàǰ
¾ÈÀü»ç¿ë ¸Þ´º¾ó
KMLE ÀÇÇпë¾î
½º¸¶Æ®Æù
µå·°ÀÎÆ÷ ¸ð¹ÙÀÏ
bottom
 
 
 
   
icon1 icon2 ¾àǰ°Ë»ö icon2 ºÎÀÛ¿ë ¹× ´ëó¹ý
 
 
È޹̶óÁÖ40mg(¾Æ´Þ¸®¹«¸¿,À¯ÀüÀÚÀçÁ¶ÇÕ)(°ü)  Humira inj. 40mg  
Àü¹®ÀǾàǰ | »èÁ¦ | ½Å¾à
¼öÀÔÀǾàǰ
 
¾Ë¸²: µå·°ÀÎÆ÷¿¡¼­´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù.
īī¿À½ºÅ丮 Æ®À§ÅÍ ÆäÀ̽ººÏ Á¤º¸°¡ºÎÁ·ÇϽŰ¡¿ä?
Àü¹®/ÀÏ¹Ý Àü¹®
¾àǰ»çÁø
¹«»öÅõ¸íÇÑ À¯¸®¿ë±â¿¡ °ÅÀÇ ¹«»öÅõ¸íÇÑ ¾×ÀÌ ÃæÀüµÇ¾î ÀÖ´Â ÁÖ»çħÀÌ ºÎÂøµÈ ÇÁ¸®Çʵå½Ã¸°Áö ¶Ç´Â ÇÁ¸®Çʵå½Ã¸°Áö°¡ ³»ºÎ¿¡ ÀåÂøµÈ ÆæÇü
»çÁø»ó¼¼º¸±â  µ¿ÀϾà½Äº°»çÁø
ȸ¿øÁ¦°ø»çÁø
Á¦Á¶È¸»ç Abbott
ÆÇ¸Åȸ»ç Çѱ¹¾Öºêºñ(ÁÖ)
Çã°¡Á¤º¸ Á¤»ó (2006.07.19)
BIT ¾àÈ¿ºÐ·ù °üÀý¿° ¹× ·ù¸¶Æ¼½º Æ÷ÇÔ ±Ù°ñ°Ý°è¾à¹°(Musculoskeletal drugs including arthritis and rheumatic diseases)
º¹ÁöºÎºÐ·ù 439[±âŸÀÇ Á¶Á÷¼¼Æ÷ÀÇ Ä¡·á ¹× Áø´Ü ]
û±¸ÄÚµå(KDÄÚµå)
   ºñ±Þ¿©Á¡°ËÄÚµå
624900102  
\0 ¿ø/0.8mL/°ü(2021.11.01)(ÇöÀç¾à°¡)
\277,188 ¿ø/0.8mL/°ü(2021.06.07) (º¯°æÀü¾à°¡)
ATCÄÚµå Adalimumab / L04AB04
NDCÄÚµå [Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
¼ººÐ / ÇÔ·® [½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

1°üÁß
Adalimumab 40mg  Á¦Ç° °Ë»ö
÷°¡Á¦ ±¸¿¬»ê, ±¸¿¬»ê³ªÆ®·ý(¹«¼ö¹°), ¸¸´ÏÅç, ¼ö»êÈ­³ªÆ®·ý, ¿°È­³ªÆ®·ý, À̼ÒÇÁ·ÎÆÇ¿Ã¾×(ÀÏȸ¿ë), ÀλêÀ̼ö¼Ò³ªÆ®·ý, ÀλêÀϼö¼Ò³ªÆ®·ý, ÁÖ»ç¿ë¼ö, ÁÖ»çħ, Æú¸®¼Ò¸£º£ÀÌÆ®80
 
  ¸¶À̵巯±×ÀúÀå ¸¶À̵巯±×µµ¿ò¸»
Ç×  ¸ñ ³»  ¿ë
  ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-02-14
 
About us |  Contact us |  FAQ |  Service ¾È³» |  ±¤°í ¹× Á¦È޾ȳ» |  °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ |  Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö |  SiteMap |  °í°´Áö¿ø